Infection Control Today Magazine

Rifampin

Two New TB Drugs Show Synergy In Vitro

Sequella, Inc., a clinical-stage biopharmaceutical company developing drugs for treatment of infectious diseases, announces the publication of studies in the journal Antimicrobial Agents and Chemotherapy on synergy between SQ109, its lead drug candidate for the treatment of ...More
July 26, 2010
Posted in News
Meningitis in Oklahoma: Health Department Update

Oklahoma state and county health officials are at the Oologah-Talala lower elementary school again today after several cases of meningococcal disease occurred in students who attend the school.Health officials will offer, with parental consent, antibiotics as a preventive ...More
March 12, 2010
Posted in News
Researchers Identify Tuberculosis Strain That Thrives on Antibiotic

Scientists have identified a strain of antibiotic-resistant tuberculosis that thrives in the presence of rifampin, a front-line drug in the treatment of tuberculosis. The bacterium was identified in a patient in China and is described in a study by researchers at the Johns ...More
December 22, 2009
Posted in News
New Treatment Option for Latent Tuberculosis

Patients who are infected with the latent form of tuberculosis (TB) show no symptoms and are not contagious, yet they pose the biggest challenge when it comes to controlling the disease. The latest study by Dr. Dick Menzies of the Research Institute of the McGill University ...More
January 22, 2009
Posted in News
Latent TB Treatment Saves Time, Money and Lives

A new way to treat patients with latent tuberculosis (TB), who are infected with TB but without symptoms, can effectively treat it in less than half the time and at a lower cost than the current standard treatment, according to researchers who conducted a multi-center, ...More
May 20, 2008
Posted in News
Infectious Disease Physician to Present on Antibiotic Resistance Associated with Antibiotic Impregnated Devices at SHEA Meeting

BLOOMINGTON, Ind. -- Today, Issam I. Raad, MD, an infectious disease physician at the University of Texas M.D. Anderson Cancer Center, will participate in a plenary session focusing on the pros and cons of using antimicrobial impregnated intravascular devices at the Society ...More
April 8, 2008
Posted in News
Older Antibiotic Gains New Respect as Potent Treatment for Tuberculosis

It has no current market, not even a prescription price. Its makers stopped commercial production years ago, because demand was so low. But an antibiotic long abandoned as a weak, low-dose treatment for tuberculosis (TB) may have found renewed purpose, this time as a ...More
December 18, 2007
Posted in News
Faster, More Accurate Tuberculosis Test is Developed

Researchers from the Johns Hopkins Bloomberg School of Public Health, the Imperial College London, Universidad Peruana Cayetano Heredia, in Lima, Peru, and other institutions have developed a simple and rapid new tuberculosis (TB) test. The test, called ...More
October 11, 2006
Posted in News
FDA Clears New Hydrophilic Antimicrobial Catheter From Cook Critical Care For U.S. Sales

BLOOMINGTON, Ind. -- Federal clearance to market a hydrophilic-coated version of Cook Critical Care's antimicrobial central venous catheter means U.S. clinicians now can bring Cook Spectrum's superior properties, which help provide protection against catheter-elated ...More
September 2, 2004
Posted in News